Coronary artery disease from isolated non-H2-Determined incompatibilities in transplanted mouse hearts

Transplantation

Volumn 91, Issue 8, 2011, Pages 847-852

  Russell, Paul S ^a   Chase, Catharine M ^a   Madsen, Joren C ^a   Hirohashi, Tsutomu ^a   Cornell, Lynn D ^b   Sproule, Thomas J ^c   Colvin, Robert B ^a   Roopenian, Derry C ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

Coronary artery disease; Heart transplant; Non H2 determined incompatibilities

Indexed keywords

H4 ANTIGEN; H60 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN; HY ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOINCOMPATIBILITY; HISTOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN GRAFT;

ANIMALS; CORONARY ARTERY DISEASE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; H-Y ANTIGEN; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; MALE; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, TRANSGENIC; MINOR HISTOCOMPATIBILITY ANTIGENS; SKIN TRANSPLANTATION; TIME FACTORS;

EID: 79954583646     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182122f82     Document Type: Article

References (35)

1. Uehara S, Chase CM, Kitchens WH, et al. NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allografts. J Immunol 2005; 175: 3424.
2. Rötzschke O, Falk K, Wallny HJ, et al. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 1990; 249: 283.
3. Simpson E, Scott D, James E, et al. Minor H antigens: Genes and peptides. Transpl Immunol 2002; 10: 115.
4. Eichwald EJ, Silmser CR. Skin. Transplant Bull 1955; 2: 148.
5. Snell GD, Stevens LC. Histocompatibility genes of mice. III. H-1 and H-4, two histocompatibility loci in the first linkage group. Immunology 1961; 4: 366.
6. Mendoza LM, Villaflor G, Eden P, et al. Distinguishing self from nonself: Immunogenicity of the murine H47 locus is determined by a single amino acid substitution in an unusual peptide. J Immunol 2001; 166: 4438.
7. Sahara H, Shastri N. Second class minors: Molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules. J Exp Med 2003; 197: 375.
8. Roopenian D, Choi EY, Brown A. The immunogenomics of minor histocompatibility antigens. Immunol Rev 2002; 190: 86.
9. Luedtke B, Pooler LM, Choi EY, et al. A single nucleotide polymorphism in the Emp3 gene defines the H4 minor histocompatibility antigen. Immunogenetics 2003; 55: 284.
10. Choi EY, Christianson GJ, Yoshimura Y, et al. Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide. Immunity 2002; 17: 593.
11. Choi EY, Yoshimura Y, Christianson GJ, et al. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: The H60 histocompatibility antigen dominates over all others. J Immunol 2001; 166: 4370.
12. Malarkannan S, Shih PP, Eden PA, et al. The molecular and functional characterization of a dominant minorHantigen, H60. J Immunol 1998; 161: 3501.
13. Diefenbach A, Jensen ER, Jamieson AM, et al. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001; 413: 165.
14. Diefenbach A, Tomasello E, Lucas M, et al. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 2002; 3: 1142.
15. Yang J, Jaramillo A, Liu W, et al. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8-cytotoxic T cells. Transplantation 2003; 76: 84.
16. Gittes RF, Russell PS. Male histocompatibility antigens in mouse endocrine tissues: Functional and histologic evidence. J Natl Cancer Inst 1961; 26: 283.
17. He C, Schenk S, Zhang Q, et al. Effects of T cell frequency and graft size on transplant outcome in mice. J Immunol 2004; 172: 240.
18. Shatry AM, Roopenian DC, Levy RB. Survival and function of MiHA epitope-specific hostCD8TMcells following ablative conditioning and HCT. Biol Blood Marrow Transplant 2007; 13: 293.
19. Takada A, Yoshida S, Kajikawa M, et al. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D. J Immunol 2008; 180: 1678.
20. Gasser S, Orsulic S, Brown EJ, et al. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005; 436: 1186.
21. Ye Z, Feng L, Huang S, et al. Expression of H60 on mice heart graft and influence of cyclosporine. Transplant Proc 2006; 38: 2168.
22. Samarakoon A, Chu H, Malarkannan S. Murine NKG2D ligands: "Double, double toil and trouble." Mol Immunol 2009; 46: 1011.
23. Kwun J, Hu H, Schadde E, et al. Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3 /mouse recipients. J Immunol 2007; 179: 8016.
24. Feng L, Ke N, Ye Z, et al. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection. Transplant Proc 2009; 41: 4332.
25. Cheng F, Feng L, Li S, et al. Yisheng injection decreases the expression of H60 and RAE-1 genes in ischemic mice liver. Transplant Proc 2006; 38: 2210.
26. Ryu SJ, Jung KM, Yoo HS, et al. Cognate CD4 help is essential for the reactivation and expansion of CD8 memory T cells directed against the hematopoietic cell-specific dominant minor histocompatibility antigen, H60. Blood 2009; 113: 4273.
27. Skoskiewicz MJ, Colvin RB, Schneeberger EE, et al. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by-interferon. J Exp Med 1985; 162: 1645.
28. Bui JD, Carayannopoulos LN, Lanier LL, et al. IFN-dependent downregulation of theNKG2Dligand H60 on tumors. J Immunol 2006; 176: 905.
29. De Mattos AM, Bennett WM, Barry JM, et al. HLA-identical sibling renal transplantation-A 21-yr single-center experience. Clin Transplant 1999; 13: 158.
30. Krieger NR, Becker BN, Heisey DM, et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation 2003; 75: 1677.
31. Billingham RE, Medawar PB. The technique of free skin grafting in mammals. J Exp Biol 1951; 28: 385.
32. Bailey DW, Usama B. A rapid method of grafting skin on tails of mice. Transplant Bull 1960; 7: 424.
33. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K and non-H-2 antigen in rejections. Transplantation 1973; 16: 343.
34. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts. I. Time course, immunogenetic and immunopathological considerations. Am J Path 1994; 144: 260.
35. Russell PS, Chase CM, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. IV. Effects of treatment with monoclonal antibodies to intercellular adhesion molecule-1 and leukocyte function-associated antigen-1. Transplantation 1995; 60: 724.